ChemoCentryx
CCXI
#3764
Rank
โ‚ฌ3.26 B
Marketcap
45,44ย โ‚ฌ
Share price
0.00%
Change (1 day)
37.67%
Change (1 year)

Revenue for ChemoCentryx (CCXI)

Revenue in 2022 (TTM): โ‚ฌ33.46 Million

According to ChemoCentryx's latest financial reports the company's current revenue (TTM ) is โ‚ฌ32.51 Million. In 2021 the company made a revenue of โ‚ฌ28.16 Million a decrease over the revenue in the year 2020 that were of โ‚ฌ52.35 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for ChemoCentryx from 2011 to 2022

Annual revenue

Year Revenue Change
2022 (TTM) โ‚ฌ33.46 M18.79%
2021 โ‚ฌ28.16 M-46.2%
2020 โ‚ฌ52.35 M63.12%
2019 โ‚ฌ32.09 M-14.37%
2018 โ‚ฌ37.47 M-45.49%
2017 โ‚ฌ68.75 M532.45%
2016 โ‚ฌ10.87 M
2015 N/A
2014 N/A-100%
2013 โ‚ฌ4.38 M7.11%
2012 โ‚ฌ4.09 M-83.2%
2011 โ‚ฌ24.38 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ84.23 B 258,937.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ55.34 B 170,098.92%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚ฌ53.45 B 164,308.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ32.53 B 99,953.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ8.68 B 26,613.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ57.48 B 176,695.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ42.37 B 130,230.65%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ38.60 B 118,622.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚ฌ15.16 B 46,534.41%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel